Getting patients faster access to clinical trials and effective treatments | Leukaemia Foundation

Getting patients faster access to clinical trials and effective treatments

Sunday, 29 January 2018


We are pleased to announce the recent appointment of Caroline Turnour as the Leukaemia Foundation’s General Manager of Research, Advocacy and Services.

A member of our national management team, Caroline will be a strong and influential advocate for the rights of all people and families affected by blood cancer and related blood disorders.

Among Carolyn’s top priorities is ensuring people with a blood cancer have timely access to state-of-the-art drugs and increased opportunities to participate in clinical trials to improve a person’s quality of life, and potentially even save their life, when other treatments options are exhausted.

Bringing 25 years of experience with her, Caroline’s most recent role was Director, Policy and Advocacy at the Royal Australasian College of Physicians following several senior policy advisor roles in government.

These positions allowed her to actively contribute to national health debates and influence positive patient outcomes.

During this time Caroline was instrumental in securing $10 million towards advancing clinical trials and the listing of 70 new medicines on the Pharmaceutical Benefits Scheme.

Working closely with government ministers, representatives and agencies such as the Pharmaceutical Benefits Advisory Committee Caroline will be based in Canberra and she says she is looking forward to creating opportunities to give people with blood cancer faster access to clinical trials and more effective treatments.

“There are many exciting new therapies on the horizon like immunotherapy and CAR-T cell therapy with the potential to increase survival rates or extend life,” said Caroline.

“I will be working closely with government agencies and leading national and global researchers to deliver the most innovative treatment options to people with a blood cancer.

The Leukaemia Foundation will continue advocating for the timely listing of new medicines on the Pharmaceutical Benefits Scheme.

Caroline is a passionate, highly-skilled health advocate and we’re looking forward to sharing with you the advances she makes on behalf of people with a blood cancer and their families.

Caroline Turnour

You can learn more about the work of the Leukaemia Foundation or make a generous gift to support families who are impacted by a blood cancer diagnosis today.